UCSF Health Joins Registry to Improve Cardiogenic Shock Treatment
UCSF’s Heart and Vascular Center participation in a new Cardiogenic Shock Registry aims to improve treatment for cardiogenic shock types.
University of California San Francisco
Science World Honors Kevan Shokat for High-Impact Cancer Research
Kevin Shokat, who developed a successful approach to drugging a protein produced by the KRAS gene, has received two prestigious scientific awards.
UCSF is No. 1 Public Recipient of National Institutes of Health Funding in 2022
UCSF is a leading recipient of National Institutes of Health (NIH) funding for research, with a focus on advancing health sciences and medicine.
An Allergy Drug Showed Promise for MS. Could They Prove It?
Proof of an over-the-counter allergy drug’s ability to reverse progression of multiple sclerosis provides monumental change for MS patients.
“Smarter” Breast Cancer Screening Measures Risk Down to Your DNA
The WISDOM 2.0 study aims to transform breast cancer screening by using a personalized approach and will expand to women as young as 30.